SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Concord Biotech Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
543960 INE338H01029 129.4003289 CONCORDBIO 0.47 15,269.26 50.73 28.77 1
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales240.80262.35194.83
Other Operating Income0.000.000.00
Other Income 8.198.136.65
Total Income248.98270.47201.48
Total Expenditure 134.87143.16122.68
PBIDT114.12127.3278.81
Interest 0.500.840.75
PBDT113.62126.4778.05
Depreciation13.5413.3013.04
Tax25.8027.7616.30
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.270.930.24
Reported Profit After Tax74.5584.4948.47
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item74.5584.4948.47
    
EPS (Unit Curr.)7.138.084.63
EPS (Adj) (Unit Curr.)7.138.084.63
Calculated EPS (Unit Curr.)7.138.084.63
Calculated EPS (Adj) (Unit Curr.)7.138.084.63
Calculated EPS (Ann.) (Unit Curr.)28.5132.3118.53
Calculated EPS (Adj) (Ann.) (Unit Curr.)28.5132.3118.53
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4610.4610.46
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)47.3948.5340.45
PBDTM(%)47.1848.2140.06
PATM(%)30.9632.2124.88